APO Research
Talk to an analyst

APO RESEARCH · REPORT

Covid-19 Treatment

Patients today have more treatment options in the battle against coronavirus disease.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

Selected research

Market Structure

Global Covid-19 Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchCovid-19 Treatment Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Covid-19 Treatment Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Covid-19 Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Covid-19 Treatment Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Covid-19 Treatment Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

Read the full market overview

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.

Report Includes

This report provides an overview of the global Covid-19 Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Covid-19 Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Covid-19 Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Covid-19 Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Covid-19 Treatment Segment by Company

Cadila Healthcare

Johnson & Johnson

ImmunoPrecise

Novartis

AstraZeneca

Cipla

AbbVie

Bayer

Regeneron Pharmaceuticals

Ascletis Pharma

GlaxoSmithKline

Gilead Sciences

Pharmstandard

Fujifilm Holdings

Zhejiang Hisun Pharmaceutical Co. Ltd

Roche

Sanofi

Pfizer

Eli Lilly

Covid-19 Treatment Segment by Type

Life Support

Antiviral Medicine

Antibody Treatments

Others

Covid-19 Treatment Segment by End User

Children

Adult

Covid-19 Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Covid-19 Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Covid-19 Treatment industry.

Chapter 3: Detailed analysis of Covid-19 Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Life Support Table 3. Key Players of Antiviral Medicine Table 4. Key Players of Antibody Treatments Table 3. Key Players of Others Table 4. Global Covid-19 Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Children Table 6. Key Players of Adult Table 7. Global Covid-19 Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Covid-19 Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Covid-19 Treatment Market Share by Region (2021-2026) Table 10. Global Covid-19 Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Covid-19 Treatment Market Share by Region (2027-2032) Table 12. Covid-19 Treatment Industry Trends Table 13. Covid-19 Treatment Industry Drivers Table 14. Covid-19 Treatment Industry Opportunities and Challenges Table 15. Covid-19 Treatment Industry Restraints Table 16. Global Covid-19 Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Covid-19 Treatment Revenue Market Share by Company (2021-2026) Table 18. Global Covid-19 Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Covid-19 Treatment Key Company Head Office and Area Served Table 20. Global Covid-19 Treatment Company, Product Type & Application Table 21. Global Covid-19 Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Covid-19 Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Covid-19 Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Covid-19 Treatment Revenue Market Share by Type (2027-2032) Table 29. Global Covid-19 Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Covid-19 Treatment Revenue Market Share by Application (2021-2026) Table 33. Global Covid-19 Treatment Revenue Market Share by Application (2027-2032) Table 34. Cadila Healthcare Company Information Table 35. Cadila Healthcare Business Overview Table 36. Cadila Healthcare Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Cadila Healthcare Covid-19 Treatment Product Portfolio Table 38. Cadila Healthcare Recent Development Table 39. Johnson & Johnson Company Information Table 40. Johnson & Johnson Business Overview Table 41. Johnson & Johnson Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Johnson & Johnson Covid-19 Treatment Product Portfolio Table 43. Johnson & Johnson Recent Development Table 44. ImmunoPrecise Company Information Table 45. ImmunoPrecise Business Overview Table 46. ImmunoPrecise Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ImmunoPrecise Covid-19 Treatment Product Portfolio Table 48. ImmunoPrecise Recent Development Table 49. Novartis Company Information Table 50. Novartis Business Overview Table 51. Novartis Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Novartis Covid-19 Treatment Product Portfolio Table 53. Novartis Recent Development Table 54. AstraZeneca Company Information Table 55. AstraZeneca Business Overview Table 56. AstraZeneca Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AstraZeneca Covid-19 Treatment Product Portfolio Table 58. AstraZeneca Recent Development Table 59. Cipla Company Information Table 60. Cipla Business Overview Table 61. Cipla Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Cipla Covid-19 Treatment Product Portfolio Table 63. Cipla Recent Development Table 64. AbbVie Company Information Table 65. AbbVie Business Overview Table 66. AbbVie Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. AbbVie Covid-19 Treatment Product Portfolio Table 68. AbbVie Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Bayer Covid-19 Treatment Product Portfolio Table 73. Bayer Recent Development Table 74. Regeneron Pharmaceuticals Company Information Table 75. Regeneron Pharmaceuticals Business Overview Table 76. Regeneron Pharmaceuticals Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Regeneron Pharmaceuticals Covid-19 Treatment Product Portfolio Table 78. Regeneron Pharmaceuticals Recent Development Table 79. Ascletis Pharma Company Information Table 80. Ascletis Pharma Business Overview Table 81. Ascletis Pharma Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Ascletis Pharma Covid-19 Treatment Product Portfolio Table 83. Ascletis Pharma Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. GlaxoSmithKline Covid-19 Treatment Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Gilead Sciences Company Information Table 90. Gilead Sciences Business Overview Table 91. Gilead Sciences Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Gilead Sciences Covid-19 Treatment Product Portfolio Table 93. Gilead Sciences Recent Development Table 94. Pharmstandard Company Information Table 95. Pharmstandard Business Overview Table 96. Pharmstandard Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Pharmstandard Covid-19 Treatment Product Portfolio Table 98. Pharmstandard Recent Development Table 99. Fujifilm Holdings Company Information Table 100. Fujifilm Holdings Business Overview Table 101. Fujifilm Holdings Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Fujifilm Holdings Covid-19 Treatment Product Portfolio Table 103. Fujifilm Holdings Recent Development Table 104. Zhejiang Hisun Pharmaceutical Co. Ltd Company Information Table 105. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview Table 106. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product Portfolio Table 108. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development Table 109. Roche Company Information Table 110. Roche Business Overview Table 111. Roche Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Roche Covid-19 Treatment Product Portfolio Table 113. Roche Recent Development Table 114. Sanofi Company Information Table 115. Sanofi Business Overview Table 116. Sanofi Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Sanofi Covid-19 Treatment Product Portfolio Table 118. Sanofi Recent Development Table 119. Pfizer Company Information Table 120. Pfizer Business Overview Table 121. Pfizer Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Pfizer Covid-19 Treatment Product Portfolio Table 123. Pfizer Recent Development Table 124. Eli Lilly Company Information Table 125. Eli Lilly Business Overview Table 126. Eli Lilly Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Eli Lilly Covid-19 Treatment Product Portfolio Table 128. Eli Lilly Recent Development Table 129. North America Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. North America Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. North America Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. North America Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. North America Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Covid-19 Treatment Market Size by Country (2021-2026) Table 135. North America Covid-19 Treatment Market Size by Country (2027-2032) Table 136. Europe Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 137. Europe Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 138. Europe Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 139. Europe Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 140. Europe Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Covid-19 Treatment Market Size by Country (2021-2026) Table 142. Europe Covid-19 Treatment Market Size by Country (2027-2032) Table 143. China Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 144. China Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 145. China Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 146. China Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 148. Asia Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 149. Asia Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 150. Asia Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 151. Asia Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Covid-19 Treatment Market Size by Country (2021-2026) Table 153. Asia Covid-19 Treatment Market Size by Country (2027-2032) Table 154. South America, Middle East & Africa Covid-19 Treatment Market Size by Type (2021-2026) & (US$ Million) Table 155. South America, Middle East & Africa Covid-19 Treatment Market Size by Type (2027-2032) & (US$ Million) Table 156. South America, Middle East & Africa Covid-19 Treatment Market Size by Application (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa Covid-19 Treatment Market Size by Application (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2021-2026) Table 160. South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Covid-19 Treatment Product Image Figure 2. Global Covid-19 Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Covid-19 Treatment Market Share by Type: 2025 VS 2032 Figure 4. Life Support Image Figure 5. Antiviral Medicine Image Figure 6. Antibody Treatments Image Figure 7. Others Image Figure 8. Global Covid-19 Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Covid-19 Treatment Market Share by Application: 2025 VS 2032 Figure 10. Children Image Figure 11. Adult Image Figure 12. Global Covid-19 Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Covid-19 Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Covid-19 Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Covid-19 Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Covid-19 Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Covid-19 Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Covid-19 Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Covid-19 Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Covid-19 Treatment Market Share by Type (2021-2032) Figure 25. North America Covid-19 Treatment Market Share by Application (2021-2032) Figure 26. North America Covid-19 Treatment Market Share by Country (2021-2032) Figure 27. United States Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Covid-19 Treatment Market Share by Type (2021-2032) Figure 32. Europe Covid-19 Treatment Market Share by Application (2021-2032) Figure 33. Europe Covid-19 Treatment Market Share by Country (2021-2032) Figure 34. Germany Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Covid-19 Treatment Market Share by Type (2021-2032) Figure 42. China Covid-19 Treatment Market Share by Application (2021-2032) Figure 43. Asia Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Covid-19 Treatment Market Share by Type (2021-2032) Figure 45. Asia Covid-19 Treatment Market Share by Application (2021-2032) Figure 46. Asia Covid-19 Treatment Market Share by Country (2021-2032) Figure 47. Japan Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Covid-19 Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Covid-19 Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Covid-19 Treatment Market Share by Country (2021-2032) Figure 57. Brazil Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Covid-19 Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Life Support
  • Antiviral Medicine
  • Antibody Treatments
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Cadila Healthcare
  • Johnson & Johnson
  • ImmunoPrecise
  • Novartis
  • AstraZeneca
  • Cipla
  • AbbVie
  • Bayer
  • Regeneron Pharmaceuticals
  • Ascletis Pharma
  • GlaxoSmithKline
  • Gilead Sciences
  • Pharmstandard
  • Fujifilm Holdings
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Roche
  • Sanofi
  • Pfizer
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Life Support
  5. 1.2.3 Antiviral Medicine
  6. 1.2.4 Antibody Treatments
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Covid-19 Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Children
  11. 1.3.3 Adult
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Covid-19 Treatment Growth Trends by Region
  14. 1.5.1 Global Covid-19 Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Covid-19 Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Covid-19 Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Covid-19 Treatment Market Dynamics
  1. 2.1 Covid-19 Treatment Industry Trends
  2. 2.2 Covid-19 Treatment Industry Drivers
  3. 2.3 Covid-19 Treatment Industry Opportunities and Challenges
  4. 2.4 Covid-19 Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Covid-19 Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Covid-19 Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Covid-19 Treatment Key Company Head office and Area Served
  4. 3.4 Global Covid-19 Treatment Company, Product Type & Application
  5. 3.5 Global Covid-19 Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Covid-19 Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Covid-19 Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Covid-19 Treatment Tier 1, Tier 2, and Tier 3
4 Covid-19 Treatment Market by Type
  1. 4.1 Global Covid-19 Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Covid-19 Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Covid-19 Treatment Market Size Share by Type (2021-2032)
5 Covid-19 Treatment Market by Application
  1. 5.1 Global Covid-19 Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Covid-19 Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Covid-19 Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cadila Healthcare
  2. 6.1.1 Cadila Healthcare Company Information
  3. 6.1.2 Cadila Healthcare Business Overview
  4. 6.1.3 Cadila Healthcare Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cadila Healthcare Covid-19 Treatment Product Portfolio
  6. 6.1.5 Cadila Healthcare Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Covid-19 Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 ImmunoPrecise
  14. 6.3.1 ImmunoPrecise Company Information
  15. 6.3.2 ImmunoPrecise Business Overview
  16. 6.3.3 ImmunoPrecise Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ImmunoPrecise Covid-19 Treatment Product Portfolio
  18. 6.3.5 ImmunoPrecise Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Covid-19 Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Covid-19 Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cipla Covid-19 Treatment Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AbbVie Covid-19 Treatment Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bayer Covid-19 Treatment Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Regeneron Pharmaceuticals
  50. 6.9.1 Regeneron Pharmaceuticals Company Information
  51. 6.9.2 Regeneron Pharmaceuticals Business Overview
  52. 6.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Product Portfolio
  54. 6.9.5 Regeneron Pharmaceuticals Recent Developments
  55. 6.10 Ascletis Pharma
  56. 6.10.1 Ascletis Pharma Company Information
  57. 6.10.2 Ascletis Pharma Business Overview
  58. 6.10.3 Ascletis Pharma Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Ascletis Pharma Covid-19 Treatment Product Portfolio
  60. 6.10.5 Ascletis Pharma Recent Developments
  61. 6.11 GlaxoSmithKline
  62. 6.11.1 GlaxoSmithKline Company Information
  63. 6.11.2 GlaxoSmithKline Business Overview
  64. 6.11.3 GlaxoSmithKline Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GlaxoSmithKline Covid-19 Treatment Product Portfolio
  66. 6.11.5 GlaxoSmithKline Recent Developments
  67. 6.12 Gilead Sciences
  68. 6.12.1 Gilead Sciences Company Information
  69. 6.12.2 Gilead Sciences Business Overview
  70. 6.12.3 Gilead Sciences Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Gilead Sciences Covid-19 Treatment Product Portfolio
  72. 6.12.5 Gilead Sciences Recent Developments
  73. 6.13 Pharmstandard
  74. 6.13.1 Pharmstandard Company Information
  75. 6.13.2 Pharmstandard Business Overview
  76. 6.13.3 Pharmstandard Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Pharmstandard Covid-19 Treatment Product Portfolio
  78. 6.13.5 Pharmstandard Recent Developments
  79. 6.14 Fujifilm Holdings
  80. 6.14.1 Fujifilm Holdings Company Information
  81. 6.14.2 Fujifilm Holdings Business Overview
  82. 6.14.3 Fujifilm Holdings Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Fujifilm Holdings Covid-19 Treatment Product Portfolio
  84. 6.14.5 Fujifilm Holdings Recent Developments
  85. 6.15 Zhejiang Hisun Pharmaceutical Co. Ltd
  86. 6.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Information
  87. 6.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
  88. 6.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product Portfolio
  90. 6.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
  91. 6.16 Roche
  92. 6.16.1 Roche Company Information
  93. 6.16.2 Roche Business Overview
  94. 6.16.3 Roche Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Roche Covid-19 Treatment Product Portfolio
  96. 6.16.5 Roche Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sanofi Covid-19 Treatment Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Pfizer
  104. 6.18.1 Pfizer Company Information
  105. 6.18.2 Pfizer Business Overview
  106. 6.18.3 Pfizer Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Pfizer Covid-19 Treatment Product Portfolio
  108. 6.18.5 Pfizer Recent Developments
  109. 6.19 Eli Lilly
  110. 6.19.1 Eli Lilly Company Information
  111. 6.19.2 Eli Lilly Business Overview
  112. 6.19.3 Eli Lilly Covid-19 Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Eli Lilly Covid-19 Treatment Product Portfolio
  114. 6.19.5 Eli Lilly Recent Developments
7 North America
  1. 7.1 North America Covid-19 Treatment Market Size (2021-2032)
  2. 7.2 North America Covid-19 Treatment Market Size by Type
  3. 7.2.1 North America Covid-19 Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Covid-19 Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Covid-19 Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Covid-19 Treatment Market Size by Application
  7. 7.3.1 North America Covid-19 Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Covid-19 Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Covid-19 Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Covid-19 Treatment Market Size by Country
  11. 7.4.1 North America Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Covid-19 Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Covid-19 Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Covid-19 Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Covid-19 Treatment Market Size (2021-2032)
  2. 8.2 Europe Covid-19 Treatment Market Size by Type
  3. 8.2.1 Europe Covid-19 Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Covid-19 Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Covid-19 Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Covid-19 Treatment Market Size by Application
  7. 8.3.1 Europe Covid-19 Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Covid-19 Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Covid-19 Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Covid-19 Treatment Market Size by Country
  11. 8.4.1 Europe Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Covid-19 Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Covid-19 Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Covid-19 Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Covid-19 Treatment Market Size (2021-2032)
  2. 9.2 China Covid-19 Treatment Market Size by Type
  3. 9.2.1 China Covid-19 Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Covid-19 Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Covid-19 Treatment Market Share by Type (2021-2032)
  6. 9.3 China Covid-19 Treatment Market Size by Application
  7. 9.3.1 China Covid-19 Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Covid-19 Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Covid-19 Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Covid-19 Treatment Market Size (2021-2032)
  2. 10.2 Asia Covid-19 Treatment Market Size by Type
  3. 10.2.1 Asia Covid-19 Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Covid-19 Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Covid-19 Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Covid-19 Treatment Market Size by Application
  7. 10.3.1 Asia Covid-19 Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Covid-19 Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Covid-19 Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Covid-19 Treatment Market Size by Country
  11. 10.4.1 Asia Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Covid-19 Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Covid-19 Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Covid-19 Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Covid-19 Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Covid-19 Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Covid-19 Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Covid-19 Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Covid-19 Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Covid-19 Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Covid-19 Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Covid-19 Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Covid-19 Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Covid-19 Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Covid-19 Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Covid-19 Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst